Advanced light microscopy techniques are giving scientists a new understanding of human biology and what goes wrong in ...

Fulcrum Therapeutics reports promising late-stage data for sickle cell drug pociredir, with notable hemoglobin improvements.

A student at Kennesaw State is helping develop a low-cost, light-based device to screen for stroke in children with sickle ...

A controversial collaboration between Duke and cord blood banker Cryo-Cell could be a worrisome sign of things to come in cell therapy.

Gene therapy for sickle cell disease may help improve a major contributing factor to stroke risk in patients, reports a new study from St. Jude Children's Research Hospital. Many people with ...

By analysing blood samples from 40 patients before and during treatment, they found that instead of disappearing during treatment, certain types of immune cell – which play a key part in asthma ...

Sickle cell disease (SCD) is an inherited, lifelong and painful blood disorder in which red blood cells are shaped like crescents instead of discs, restricting blood flow and causing organ damage.

Vertex Pharmaceuticals may have narrowed its focus this year, but the biopharma’s decision to stick with its remaining islet cell therapy ...

Families of those who have sickle cell disease in the Philadelphia area are pushing for more research and a cure.

Among its positive recommendations, Europe’s CHMP has blessed ExCellThera’s Zemcelpro, a first-of-its-kind treatment for adults with blood cancers.

Ogbuku noted that sickle cell disease affects thousands of individuals and families in the Niger Delta, with many lacking access to early diagnosis, counseling, and treatment.

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no suitable donor.